Press Releases

SCOTTSDALE, Ariz., Aug. 30, 2019 /PRNewswire/ -- Healthcare Trust of America, Inc. (NYSE:HTA or the "Company"), announced investment activity of over $200 million in new development projects and acquisitions since June 30, 2019. These include the announcement of two on-campus medical office building ("MOB"

WESTON, Fla., Aug. 30, 2019 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF), in collaboration with Cleveland Clinic Florida, will host the 1st Annual Collaborative International Gastric Cancer Education Symposium and Live Webcast featuring a panel of leading oncologists and healthcare experts from around the world. The event

AMERICAN FORK, Utah, Aug. 30, 2019 /PRNewswire/ -- As eAssist Dental Solutions (www.dentalbilling.com) continues to grow, they have earned a

EMERYVILLE, Calif., Aug. 30, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that management will be presenting at the H.C. Wainwright 21st Annual Global Investment Conference to be held

SUMMIT, N.J., Aug. 30, 2019 /PRNewswire/ -- Seqirus, a global leader in influenza prevention, today presented data at the Options for the Control of Influenza (OPTIONS X) Conference in Singapore from clinical studies demonstrating the ability of a MF59® adjuvanted influenza vaccine to increase immune responses when used in

TORONTO, Aug. 30, 2019 /PRNewswire/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF)

TORONTO, Aug. 30, 2019 /PRNewswire/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF)

BALTIMORE, Aug. 30, 2019 /PRNewswire/ -- Prostate cancer is the second most common cancer for men, both in the United States and worldwide. In 2019, nearly 175,000 US men will be told they have prostate cancer – that is one new case every 3 minutes. Globally, the number increases to one new case every 41 seconds.

SAN DIEGO, Aug. 30, 2019 /PRNewswire/ -- Reneo Pharmaceuticals, a clinical stage pharmaceutical company, today announced that Alex Dorenbaum, MD, chief m

SAN DIEGO and VANCOUVER, British Columbia, Aug. 30, 2019 /PRNewswire/ -- Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for the treatment of patients with urological diseas